Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Chronic>Ph+ *
>
Treatment
>
Co.: USA. B. Brand Dasatinib**
>
Patent>US Expiration:2020. 04.03
Patent>US Expiration:2020. 04.03's products
This section has no products